CDKN1A and osteosarcoma: In conclusion, our results provide evidence for a potential pathway through which the activation of the TNF‐α/NF‐κB axis positively regulates CRL4BDCAF11 activity, causing p21Cip1 degradation and the disruption of cell cycle progression in human osteosarcoma cells (Fig. 8).